Assenagon Asset Management S.A. Deciphera Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$12.46 - $15.48 $482,314 - $599,215	-38,709 Reduced 4.56%	809,923 $10.3 Million
Q1 2023 Apr 18, 2023	SELL	$14.26 - $22.1 $2.39 Million - $3.7 Million	-167,447 Reduced 16.48%	848,632 $13.1 Million
Q4 2022 Jan 12, 2023	SELL	$14.85 - $19.04 $5.76 Million - $7.38 Million	-387,742 Reduced 27.62%	1,016,079 $16.7 Million
Q3 2022 Oct 27, 2022	BUY	$12.38 - $20.23 $8.65 Million - $14.1 Million	699,071 Added 99.19%	1,403,821 $26 Million
Q2 2022 Jul 27, 2022	SELL	$9.11 - $13.98 $1.38 Million - $2.11 Million	-150,949 Reduced 17.64%	704,750 $9.27 Million
Q1 2022 Apr 25, 2022	BUY	$6.87 - $11.11 $4.2 Million - $6.79 Million	611,334 Added 250.17%	855,699 $7.93 Million
Q4 2021 Feb 01, 2022	BUY	$7.7 - $37.13 $1.69 Million - $8.16 Million	219,874 Added 897.77%	244,365 $2.39 Million
Q3 2021 Oct 19, 2021	SELL	$26.46 - $37.15 $39,240 - $55,093	-1,483 Reduced 5.71%	24,491 $832,000
Q2 2021 Jul 15, 2021	BUY	$32.73 - $47.95 $850,129 - $1.25 Million	25,974 New	25,974 $951,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.